Kinesio taping, or “KT tape”, which is widely used to relieve joint and muscle pain and increase range of motion, may not be all that effective, suggests a pooled data analysis of existing evidence published in the online journal BMJ Evidence-based medicine.
The cotton-based, breathable adhesive tape, commonly used on the bodies of high-profile athletes, athletes and women, may have immediate or short-term benefits, but researchers say current evidence is “highly uncertain”.
The researchers concluded that the lack of strong evidence, as well as the associated potential for skin irritation, may limit its use in clinical practice.
Kinesio (KT) taping was originally invented in the 1970s and has been widely used to reduce discomfort and increase mobility in musculoskeletal disorders, researchers explain.
When applied correctly, it is thought to have the effect of lifting the skin, stimulating sensory receptors, and promoting local blood circulation, but several recent clinical trials have reported inconsistent results regarding its use, they added.
To clarify the current body of evidence, researchers set out to summarize findings regarding the use of KT taping for pain intensity, function/disability, range of motion, muscle strength, quality of life, and specific disease symptoms.
They scoured research databases for relevant systematic reviews on the use of KT taping as a primary treatment for musculoskeletal disorders, spanning the period from introduction to October 2025.
Their pooled data analysis included 128 English-language systematic reviews, of which 73 were published and 55 of which were registered but not yet published. These reviews covered 310 individual randomized clinical trials with 15,812 participants and 29 musculoskeletal diseases over different treatment periods.
Most reviews focused on symptoms affecting the legs and feet (45%) and pain intensity (89%).
Collectively, the results of the systematic review showed that KT taping may reduce pain intensity in the immediate and short term and improve function/disability immediately, but the evidence is highly uncertain.
This includes use for a variety of common conditions, including after knee surgery, chronic knee and back pain, knee osteoarthritis, tennis elbow (lateral elbow tendinopathy), and plantar fasciitis.
Inconclusive evidence also suggests that KT taping may have minor or negligible effects on medium-term pain intensity, short- and medium-term function/disability, muscle strength, range of motion, and disease-specific musculoskeletal symptoms.
Although KT taping may be only marginally superior (i.e., minimally clinically important difference) to placebo/sham taping, the certainty of this evidence is low and its effects may vary by patient group and condition, the researchers note.
Only 19 trials reported on side effects, the most common of which was dermatitis.
(40%) and itching (30%). These usually resolve without further treatment, but skin irritation and itching “remain a concern”, researchers say.
There was not enough evidence to confirm whether KT taping improves the quality of life of people with musculoskeletal conditions.
Most of the systematic reviews (57, 78%) had flaws in methodology and varied widely in design. And there is a significant degree of overlap between them, the researchers stress, making it difficult to provide firm recommendations for their use.
They concluded that “the current evidence is highly uncertain regarding the clinical efficacy of KT (taping) for musculoskeletal disorders. Considerable heterogeneity, unclear clinical relevance, and potential (side effects) may limit its application in clinical practice.”
sauce:
Reference magazines:
Moon, Q, others. (2026). Efficacy and clinical relevance of kinesiotaping in musculoskeletal disorders: Overview of a systematic review and evidence mapping. BMJ Evidence-based medicine. DOI: 10.1136/bmjebm-2025-114067. https://ebm.bmj.com/content/early/2026/03/23/bmjebm-2025-114067
